SCHEMBL21883590

SCHEMBL21883590

CCCCCCc1nccc(C)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.45
PTGS2 P35354 3/20 0.43
ESR1 P03372 2/20 0.43
ADRA2A P08913 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
TACR2 P21452 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
TP53 P04637 2/20 0.43
CYP3A4 P08684 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
SHBG P04278 1/20 0.43
HSPD1 P10809 1/20 0.43
ADRB3 P13945 1/20 0.43
HTR2C P28335 1/20 0.43
HSPE1 P61604 1/20 0.43
HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31282524 0.84 NOS2 (0.41) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL28182429 0.84 NOS2 (0.41) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL28323117 0.84 NOS2 (0.41) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL28182387 0.84 NOS2 (0.41) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL31283581 0.84 NOS2 (0.41) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL18062080 0.83 NOS2 (0.44) PTGS2KDM4EALDH1A1PTGS1L3MBTL1
SCHEMBL19005863 0.81 NOS2 (0.42) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL21883574 0.81 NOS2 (0.46) KDM4EALDH1A1HSD17B10TBXAS1TDP1
SCHEMBL21883774 0.77 HSD17B10 (0.40) TYRPTGS2ESR1ADRA2AADORA3
SCHEMBL9878422 0.77 TDP1 (0.36) PTGS2ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597377-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 TYR 681/4885PTGS2 1938/4885ESR1 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.